26-18-102. DUR Board -- Creation and membership -- Expenses.
(1) There is created a 12-member Drug Utilization Review Board responsible for
implementation of a retrospective and prospective DUR program.
(2) (a) Except as required by Subsection (b), as terms of current board members expire,
the executive director shall appoint each new member or reappointed member to a four-year
term.
(b) Notwithstanding the requirements of Subsection (a), the executive director shall, at
the time of appointment or reappointment, adjust the length of terms to ensure that the terms of
board members are staggered so that approximately half of the board is appointed every two
years.
(c) Persons appointed to the board may be reappointed upon completion of their terms,
but may not serve more than two consecutive terms.
(d) The executive director shall provide for geographic balance in representation on the
board.
(3) When a vacancy occurs in the membership for any reason, the replacement shall be
appointed for the unexpired term.
(4) The membership shall be comprised of the following:
(a) four physicians who are actively engaged in the practice of medicine or osteopathic
medicine in this state, to be selected from a list of nominees provided by the Utah Medical
Association;
(b) one physician in this state who is actively engaged in academic medicine;
(c) three pharmacists who are actively practicing in retail pharmacy in this state, to be
selected from a list of nominees provided by the Utah Pharmaceutical Association;
(d) one pharmacist who is actively engaged in academic pharmacy;
(e) one person who shall represent consumers;
(f) one person who shall represent pharmaceutical manufacturers, to be recommended by
the Pharmaceutical Manufacturers Association; and
(g) one dentist licensed to practice in this state under Title 58, Chapter 69, Dentists and
Dental Hygienists Act, who is actively engaged in the practice of dentistry, nominated by the
Utah Dental Association.
(5) Physician and pharmacist members of the board shall have expertise in clinically
appropriate prescribing and dispensing of outpatient drugs.
(6) The board shall elect a chair from among its members who shall serve a one-year
term, and may serve consecutive terms.
(7) (a) Members shall receive no compensation or benefits for their services, but may
receive per diem and expenses incurred in the performance of the member's official duties at the
rates established by the Division of Finance under Sections 63A-3-106 and 63A-3-107.
(b) Members may decline to receive per diem and expenses for their service.
(c) (i) Higher education members who do not receive salary, per diem, or expenses from
the entity that they represent for their service may receive per diem and expenses incurred in the
performance of their official duties from the committee at the rates established by the Division of
Finance under Sections 63A-3-106 and 63A-3-107.
(ii) Higher education members may decline to receive per diem and expenses for their
service.
Amended by Chapter 243, 1996 General Session
Download Code Section Zipped WordPerfect 26_18_010200.ZIP 3,257 Bytes
Sections in this Chapter|Chapters in this Title|All Titles|Legislative Home Page
Last revised: Thursday, May 28, 2009